GlobeImmune Receives $17,508,500 New Round

  • Feed Type
  • Date
    3/31/2010
  • Company Name
    GlobeImmune
  • Mailing Address
    1450 Infinite Drive Louisville, CO 80027
  • Company Description
    GlobeImmune, Inc., is a biopharmaceutical company pioneering the discovery, development and manufacturing of potent, targeted molecular immunotherapy products called Tarmogens for the treatment of cancer and infectious diseases.
  • Website
    http://www.globeimmune.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,508,500
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Adams Harkness Ventures
  • Venture Investor
    Eminent Capital Partners
  • Venture Investor
    HealthCare Ventures
  • Venture Investor
    Lilly Ventures
  • Venture Investor
    Medica Venture Partners
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    Pac-Link Bio
  • Venture Investor
    Sequel Venture Partners
  • Venture Investor
    WRF Capital
  • Venture Investor
    Yasuda Enterprise Development
  • Venture Investor
    Undisclosed

Trending on Xconomy